Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.
about
An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndromeNovel UHPLC-MS/MS method for the determination of rotigotine in the plasma of patients with Parkinson's disease.Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.ADMET considerations for restless leg syndrome drug treatments.Anti-Parkinson's disease drugs and pharmacogenetic considerations.Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine.Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration.
P2860
Q35244136-59FBE951-16F2-4B72-846D-77AFB17D1DE5Q36272548-1DC82325-13A5-4AC8-AD67-C87D1CA9BE7EQ37506391-72AA0CF4-A7DC-443B-8803-CD8BAF768545Q38027180-00B3F2EB-44D3-462B-9CAF-DDE1343F8D15Q38097097-BC246DA0-9160-4BDA-8906-7D694D3781C8Q38242043-284F5571-2807-4A66-BC1A-A85813EF7EDDQ38242390-E14BA33F-D711-4E8F-97FD-33515A9B02FBQ38870973-5460E30E-C5E9-4BD8-A221-98044328A702Q45086483-91CC6F62-D16B-40E7-9369-B75AF3E0D422Q51044433-FC834BD1-75A6-43EE-A3A6-AF8CA3DB0875
P2860
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Single dose pharmacokinetics o ...... with impaired renal function.
@ast
Single dose pharmacokinetics o ...... with impaired renal function.
@en
type
label
Single dose pharmacokinetics o ...... with impaired renal function.
@ast
Single dose pharmacokinetics o ...... with impaired renal function.
@en
prefLabel
Single dose pharmacokinetics o ...... with impaired renal function.
@ast
Single dose pharmacokinetics o ...... with impaired renal function.
@en
P2093
P2860
P1476
Single dose pharmacokinetics o ...... with impaired renal function.
@en
P2093
Agnieszka Szymczakiewicz-Multanowska
Marina Braun
Sascha Ahrweiler
Willi Cawello
Wladyslaw Sulowicz
P2860
P356
10.1111/J.1365-2125.2011.04053.X
P407
P577
2012-01-01T00:00:00Z